LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Deutsche Bank Securities 33rd Annual Health Care Conference on Monday, May 5, 2008 at 2:40 p.m. (ET) at the InterContinental Hotel in Boston.
